Date of Award

2024

Document Type

Thesis (Ph.D.)

Department or Program

Engineering Sciences

First Advisor

Jiwon Lee

Abstract

Adaptive immunity, comprised in part by the antibody repertoire, is the cornerstone of our ability to remain healthy amongst the plethora of pathogenic challenges we encounter daily. Despite the importance of understanding antibody repertoire development, much remains unknown about the composition and evolution of circulating antibodies in response to viral challenges. To better understand antibody repertoire development, we profiled the serum antibody repertoire using a combination of next-generation sequencing and serum antibody proteomics in the predominantly naïve response against SARS-CoV-2 spike and the recalled response to influenza hemagglutinin. The response to SARS-CoV-2 spike in four convalescent individuals was diverse (consisting of between 59 and 167 clonotypes) and predominately targeted regions of the protein which were inaccessible on prefusion spike and likely non-protective. Only a small fraction of these antibodies could target any tested SARS-CoV-2 variants. Few of the recombinantly expressed antibodies neutralized the virus, and those that did neutralize were orders of magnitude weaker than a representative therapeutic antibody; however, all antibodies showed ADCP, ADCC, and ADCD activity. In one donor, an antibody with high binding to another human coronavirus, HKU1, dominated the serum repertoire and had levels of somatic hypermutation commonly observed in recalled antibodies. This antibody was the only among a panel we characterized which maintained binding to the highly mutated B.1.1.529 variant.

Available for download on Sunday, September 13, 2026

Share

COinS